CAS 1238517-16-2

Indatuximab ravtansine

CAS: 1238517-16-2

Indatuximab ravtansine (BT-062) is an antibody-drug conjugate (ADC) (Antibody-Drug Conjugates (ADCs)) that consists of a murine-human chimeric form based on B-B4, which specifically targets CD138, linked via a disulfide bond to the maytansinoid drug DM4. It exhibits antitumor activity.

Colore e forma: Liquid

Ref: TM-T9901A-224

Indatuximab ravtansine

CAS: 1238517-16-2

Antibody-drug conjugate (ADC) of anti-CD138 chimerized MAb (nBT062) linked to the maytansinoid DM4

Ref: 3D-CLA1045